You are here

Article Text

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Scleroderma, myositis and related syndromes - clinical aspects and treatment
AB0609 Fluorescence Optical Imaging of Inflammation in Systemic Sclerosis – A Pilot Study
  1. A. Pfeil1,
  2. K.F. Drummer1,
  3. J. Boettcher2,
  4. C. Jung3,
  5. P. Oelzner1,
  6. G. Wolf1
  1. 1Department Of Internal Medicine III, Friedrich-Schiller-Univerisity Jena, Jena
  2. 2Institute of Diagnostic and Interventional Radiology, SRH Waldklinikum Gera, Gera
  3. 3Department Of Internal Medicine I, Friedrich-Schiller-Univerisity Jena, Jena, Germany

Abstract

Background Systemic sclerosis is a connective tissue disease affecting various organs including the peripheral vessels resulting in Raynaud's phenomenon. For treatment of Raynaud's phenomenon the vasodilator Prostaglandin I2 analogue iloprost is widely used. An anti-inflammatory and immunmodulating effect is also described for iloprost. Fluorescence optical imaging (FOI) is an in vivo technique to visualize inflammation based on the accumulation of fluorescence optical contrast media (indocyanine green) in rheumatoid arthritis.

Objectives The aim of this study was to visualize inflammation using FOI in patients with Systemic Sclerosis (SSc) with SSc-related Raynaud's phenomenon depended and to clarify therapeutic response depending on the treatment with iloprost.

Methods 16 patients with SSc and Raynaud's phenomenon were prospectively included. The SSc patients were intravenously treated with over seven days. FOI (Xiralite system, Mivenion GmbH, Berlin, Germany) was performed at baseline and after seven days using on intravenous application of indocyanine green (ICG). Both hands were investigated, divided into 19 segments per hand (total 38 segments). Segments of both hands were quantitatively evaluated to determine enhancement of ICG.

Results In total 798 hand segments were scored considering all patients with SSc. At baseline 31.5% hand segments showed an ICG enhancement. The highest ICG enhancement was observed at the proximal phalanx of all fingers. After seven days of iloprost therapy a significant reduction of visible ICG enhancement was verified with -40.9% (p<0.001).

Conclusions The FOI technique seems to consists a high potential to visualize inflammation in patients with SSc and Raynaud's phenomenon. The anti-inflammatory effects of iloprost were detectable using the FOI based on the reduced enhancement of ICG. FOI offers a promising impact for the diagnosis and therapy monitoring of patients with SSc associated with Raynaud's phenomenon.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.3271

https://doi.org/10.1136/annrheumdis-2014-eular.3271

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.